Compound ID | 695
Class: Antimicrobial peptide
| Agent Type: | Natural product; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor. Lipid II inhibitor; forms complex with precursor lipid II |
| Target Pathogen: | Active against Staphylococcus aureus, Staphylococcus epidermidis, and Enterococcus faecium |
| Description: | Natural product from Eurotium amstelodami; defensin-type |
| Institute where first reported: | Novozymes A/S, Denmark |
| Year first mentioned: | 2007 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/protein/K7N5L0 |
| Citation: | https://doi.org/10.1074/jbc.M112.382028 |